Literature DB >> 31899086

The Crystal Structure of Angiotensin II Type 2 Receptor with Endogenous Peptide Hormone.

Hidetsugu Asada1, Asuka Inoue2, Francois Marie Ngako Kadji3, Kunio Hirata4, Yuki Shiimura5, Dohyun Im6, Tatsuro Shimamura6, Norimichi Nomura6, Hiroko Iwanari7, Takao Hamakubo7, Osamu Kusano-Arai7, Hiromi Hisano6, Tomoko Uemura6, Chiyo Suno6, Junken Aoki8, So Iwata9.   

Abstract

Angiotensin II (AngII) is a peptide hormone that plays a key role in regulating blood pressure, and its interactions with the G protein-coupled receptors, AngII type-1 receptor (AT1R) and AngII type-2 receptor (AT2R), are central to its mechanism of action. We solved the crystal structure of human AT2R bound to AngII and its specific antibody at 3.2-Å resolution. AngII (full agonist) and [Sar1, Ile8]-AngII (partial agonist) interact with AT2R in a similar fashion, except at the bottom of the AT2R ligand-binding pocket. In particular, the residues including Met1283.36, which constitute the deep end of the cavity, play important roles in angiotensin receptor (ATR) activation upon AngII binding. These differences that occur upon endogenous ligand binding may contribute to a structural change in AT2R, leading to normalization of the non-canonical coordination of helix 8. Our results will inform the design of more effective ligands for ATRs.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G protein coupled receptor; X-ray crystal structure; angiotensin receptor; peptide hormon

Mesh:

Substances:

Year:  2019        PMID: 31899086     DOI: 10.1016/j.str.2019.12.003

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  16 in total

1.  Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma.

Authors:  Richard Perryman; Alexander Renziehausen; Hamidreza Shaye; Androniki D Kostagianni; Antonis D Tsiailanis; Thomas Thorne; Maria V Chatziathanasiadou; Gregory B Sivolapenko; Mohamed Ahmed El Mubarak; Gye Won Han; Barbara Zarzycka; Vsevolod Katritch; Guillaume Lebon; Cristiana Lo Nigro; Laura Lattanzio; Sophie V Morse; James J Choi; Kevin O'Neill; Zoi Kanaki; Apostolos Klinakis; Tim Crook; Vadim Cherezov; Andreas G Tzakos; Nelofer Syed
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-02       Impact factor: 12.779

Review 2.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 3.  Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  Br J Pharmacol       Date:  2022-04-23       Impact factor: 9.473

Review 4.  Structural insights into ligand recognition and activation of angiotensin receptors.

Authors:  Haitao Zhang; Aleksandra Luginina; Alexey Mishin; Mithu Baidya; Arun K Shukla; Vadim Cherezov
Journal:  Trends Pharmacol Sci       Date:  2021-05-10       Impact factor: 14.819

5.  Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.

Authors:  Silvana Vasile; Anders Hallberg; Jessica Sallander; Mathias Hallberg; Johan Åqvist; Hugo Gutiérrez-de-Terán
Journal:  Biomolecules       Date:  2020-04-23

6.  Cryo-EM structures of human bradykinin receptor-Gq proteins complexes.

Authors:  Jinkang Shen; Dongqi Zhang; Yao Fu; Anqi Chen; Xiaoli Yang; Haitao Zhang
Journal:  Nat Commun       Date:  2022-02-07       Impact factor: 17.694

Review 7.  Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders.

Authors:  Farrah Syazana Khattulanuar; Mahendran Sekar; Shivkanya Fuloria; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Subban Ravi; Kumarappan Chidambaram; M Yasmin Begum; Abul Kalam Azad; Srikanth Jeyabalan; Arulmozhi Dhiravidamani; Lakshmi Thangavelu; Pei Teng Lum; Vetriselvan Subramaniyan; Yuan Seng Wu; Kathiresan V Sathasivam; Neeraj Kumar Fuloria
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

8.  Breaking the Enigma Code of Angiotensin II Type 2 Receptor Signaling.

Authors:  Anastasiia Sadybekov; Vsevolod Katritch
Journal:  Structure       Date:  2020-04-07       Impact factor: 5.006

Review 9.  Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.

Authors:  Samantha L Cooper; Eleanor Boyle; Sophie R Jefferson; Calum R A Heslop; Pirathini Mohan; Gearry G J Mohanraj; Hamza A Sidow; Rory C P Tan; Stephen J Hill; Jeanette Woolard
Journal:  Int J Mol Sci       Date:  2021-07-31       Impact factor: 6.208

Review 10.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.